About Zühlke
Zühlke is a venture capital firm founded in 1968. It is primarily based out of Schlieren, Switzerland. As of Sep 2025, Zühlke is an active investor, having invested in 17 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in Switzerland based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and High Tech. Most recently it participated in the $***** Seed round of PeriVision Overall, Zühlke portfolio has seen 1 IPO and 3 acquisitions including key companies like Broadridge, Noctrix Health and Aluna. A lot of funds co-invest with Zühlke, with names like Arboretum Ventures sharing a substantial percentage of its portfolio. Zühlke has team of 18 people including 16 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Seed
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Zühlke's List of Top Investments
Zühlke has a portfolio of 17 companies. Their most notable investments are in Distalmotion and Swisstom.Their portfolio spans across Switzerland, United States, Canada and 1 more locations. They have invested in HealthTech, Life Sciences, High Tech and 7 other sectors, across stages such as Series A, Seed stages. Here is the list of top investments by Zühlke:
1. Broadridge
Provider of tech solution for financial service and customer communication. It is a global technology leader with the trusted expertise and transformative technology to help clients and the financial services industry operate, innovate, and grow. Its industry-leading products and services empower you to meet regulatory requirements, navigate risk, allocate resources more effectively, and drive top-line revenue growth. It transform and simplify global trading and post-trade operations across the trade lifecycle with innovative, modular, multi-asset solutions that increase efficiency, reduce risk and drive revenue, amplify shareholder engagement with seamless, industry-leading solutions that efficiently meet compliance obligations, tap into an expansive suite of technology, regulatory, and communications solutions that enable wealth firms to grow and transform on their own terms and automate and efficiently deliver key customer communications across industries with leading expertise and omni-channel capabilities.
Key facts about Broadridge
- Founded Year: 2007
- Location: United States
- Annual Revenue: $1B+ as on Jun 30, 2025
- Stage: Public
- Employee Count: 17,918 as on Jul 31, 2026
- Investors: Back Bay Group, Zühlke and 4 Others
- Latest Funding Round: Conventional Debt, Apr 04, 2019, $*****
- Highlight: Public
2. Koya Medical
Provider of smart wearable compression technology for lymphedema and venous diseases. The company offers its flagship product Dayspring system which is an FDA-cleared wearable device which offers an active compression system and pump. The device is integrated with an app that indicated the treatment of lymphedema, venous insufficiency, and wound healing time. The device uses patented Flexframe technology.
Key facts about Koya Medical
- Founded Year: 2018
- Location: Oakland (United States)
- Stage: Series B
- Total Funding till date: $37M
- Employee Count: 188 as on Jul 31, 2026
- Investors: Orbimed, Zühlke and 10 Others
- Latest Funding Round: Series B, Nov 15, 2023, $*****
- Highlight: Editors' Pick
Provider of a wearable device for stress and anxiety management. The platform provides a Flow neural stimulator headset for depression treatment. The device tDCS headset delivers a gentle current to the forehead to reverse the activity imbalance observed in people with depression and training the brain to kick negative behaviours. The mobile app also provides exercises, meditation, and mindfulness programs.
Key facts about Flow Neuroscience
- Founded Year: 2016
- Location: Malmo (Sweden)
- Stage: Series A
- Total Funding till date: $11.9M
- Employee Count: 41 as on Jul 31, 2026
- Investors: Khosla Ventures, Zühlke and 6 Others
- Latest Funding Round: Series A, Aug 11, 2021, $*****
- Highlight: Editors' Pick
Noctrix Health is engaged in developing prescription-grade wearable therapeutic devices. They are developing a medical device for treating chronic neurological disorders, especially to treat the symptoms of restless leg syndrome.
Key facts about Noctrix Health
- Founded Year: 2016
- Location: San Francisco (United States)
- Stage: Acquired
- Total Funding till date: $90.5M
- Employee Count: 163 as on Jul 31, 2026
- Investors: Orbimed, Sectoral and 15 Others
- Latest Funding Round: Series C, Aug 29, 2025, $*****
- Highlight: Acquired
5. Distalmotion
Developer of robotic devices for surgical procedures. It develops DEXTER, a hybrid surgical robot that simplifies robotic-assisted minimally invasive surgery for hospitals and outpatient settings. It consists of fully articulated, single-use 8 mm instruments for suturing and dissection, like needle drivers, Johann graspers, monopolar scissors, and bipolar Maryland forceps. The device also provides the option to switch between laparoscopic and robotic surgery at any time during surgery.
Key facts about Distalmotion
- Founded Year: 2012
- Location: Epalinges (Switzerland)
- Stage: Series G
- Total Funding till date: $390M
- Employee Count: 213 as on Jul 31, 2026
- Investors: Zühlke, EuroUS Ventures and 10 Others
- Latest Funding Round: Series G, Jan 12, 2026, $*****
- Highlight: Editors' Pick
Zühlke's Year-on-Year Investment Trends
Zühlke has invested in 17 companies over the last 13 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in PeriVision.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
2023 | 0 | 0 | 0 |
2022 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
Zühlke's Investments by Stage
Zühlke has made 6 investments in Series A stage with an average round size of $8.21M and 3 investments in Seed stage with an average round size of $3.63M.Stage of entry | No. of Investments |
|---|---|
Series A | 6 |
Seed | 3 |
Note: We have considered here, only first round of investments
Zühlke's Investments by Sector
Zühlke has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, High Tech, Internet of Things - Industry Applications and Consumer. Notably, it has invested in 15 Tech companies, 12 Enterprise (B2B) companies, 10 Tech hardware companies and at least 9 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
HealthTech | 4 |
High Tech | 3 |
Internet of Things - Industry Applications | 2 |
Consumer | 1 |
Others | 5 |
Note: We have considered here, only first round of investments
Zühlke's Investments by Geography
Zühlke has made most investments in Switzerland (6), followed by United States where it has made 2 investments.Country | No. of Investments |
|---|---|
Switzerland | 6 |
United States | 2 |
Sweden | 1 |
Note: We have considered here, only first round of investments
Zühlke's recent investments
Zühlke has not made any investment in 2026 so far.Here are the most recent investments by Zühlke:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 16, 2025 | Switzerland | Seed | 7553 | [+7] | |
May 21, 2024 | Switzerland | Seed | 1733 | ||
Dec 15, 2022 | Switzerland | Series A | 8685 | [+1] | |
Sep 15, 2021 | Switzerland | Seed | 4872 | - | |
Aug 11, 2021 | Sweden | Series A | 9862 | [+1] |
IPOs and Publicly Listed companies in Zühlke's Portfolio
1 of Zühlke's portfolio company became public - Broadridge. It got listed on the New York Stock Exchange (NYSE), in Mar 2007.Here are Zühlke's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 23, 2007 | - | - | 7976 |
Acquired companies in Zühlke's Portfolio
3 companies from Zühlke's portfolio have been acquired. The most recent acquisition was Noctrix Health in Apr 2026 by ResMed for $*****.Here are Zühlke's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 30, 2026 | - | - | 9467 | |
May 16, 2025 | - | - | 6629 | |
Jul 20, 2018 | Jul 17, 2014 | Series A | 9424 |
Team profile of Zühlke
Zühlke has a team of 18 members including 16 Partners and 1 Principal located in Switzerland, United Kingdom and 5 more locations. Zühlke's team does not sit on the board of any company as of now.Here is a list of top team members in Zühlke:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Zurich | - | ||
Partner | Zurich | - | - | |
Partner | - | - | - | |
Partner | Zurich | - | ||
Partner | Belgrade | - | ||
Partner | Frankfurt Am Main | - | ||
Partner | Zurich | - | - | |
Partner | Zurich | - | ||
Partner | London | - | ||
Partner | - | - | - |
Co-investors of Zühlke
Over the past 13 years, 41 investors have co-invested in Zühlke's portfolio companies. This includes funds and angels.
- Invested before Zühlke: Biopole, FIT and 10 others have invested in rounds before Zühlke. There are 2 companies where Biopole has invested before Zühlke and 2 companies where FIT has invested before Zühlke.
- Top Co-investors of Zühlke: 20 investors entered a company along with Zühlke. These include investors like Arboretum Ventures (1 company).
- Invested after Zühlke: A total of 9 investors have invested in Zühlke's portfolio after their investments. Top Investors include 3x5 Partners (1 company), Asahi Kasei (1 company) and Cadence Healthcare Ventures (1 company).
Recent News related to Zühlke
•
•
Biotech Limula secures $6.8M for gene therapyTech.eu•May 21, 2024•Limula, Life Extension Ventures, Verve Ventures, Zühlke and 3 others
•
•
Zühlke adds Group Head of Talent at fast-growing Scottish officeScottish Business News•Oct 30, 2023•Zühlke
•
•
•
Co-op Group announces partnership with Zühlke UK as it looks to expand its technology capabilitiesRetail Technology Innovation Hub•Jun 22, 2023•Zühlke, Co-op
•
•
•
